- Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
- Springer Japan
- Published Date:
- Paperback / softback
- Product Dim.:
- 9.25 H x 6.10 W (inches)
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia provides a comprehensive understanding of the recent molecular genetics of Chronic Myelogenous Leukemia (CML) and a characterization of the molecular targets for drug development. Included are therapeutic implications, diagnosis, and prognosis for understanding and facilitating daily practice in the management of patients with CML.Understanding of the pathogenesis and therapy of hematological malignancies such as CML has grown significantly in recent years. This development owe much to the progress in molecular biology and now makes a major contribution to diagnosis and to treatment that pharmacologically targets the molecular events of CML. Molecular targeting therapy with newly developed agents such as small molecules and antibodies for hematological malignancies are being discovered after years of research. Some of these, including tyrosine kinase inhibitors such as imatinib, nilotinib, and dasatinib, lead to increased survival rates and improved therapies. With the opinion leaders of basic and clinical research in the field as authors, this book reviews recent advances in the biology of CML.
Special Offers and Promotions
Our print to order bookstore saves you money. There are currently no special offers for Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
Thank you for selecting our online bookstore. Currently, there are no editorial book reviews for Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
About Pubgraphics Direct
PGDirect is an online bookstore that has embraced the concept of direct to consumer selling for self-published books, softcover and hardcover books, specialty books, children's books, hard to find books, college textbooks, print on demand books and more.